Symbols / VANI
VANI Chart
About
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 103.13M |
| Enterprise Value | 106.86M | Income | -26.03M | Sales | — |
| Book/sh | 0.02 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 37 | IPO | — |
| P/E | — | Forward P/E | -3.63 | PEG | — |
| P/S | — | P/B | 60.48 | P/C | — |
| EV/EBITDA | -3.99 | EV/Sales | — | Quick Ratio | 0.48 |
| Current Ratio | 0.61 | Debt/Eq | 1397.48 | LT Debt/Eq | — |
| EPS (ttm) | -0.45 | EPS next Y | -0.35 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-31 | ROA | -50.05% |
| ROE | -265.02% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 81.21M |
| Shs Float | 32.56M | Short Float | 0.69% | Short Ratio | 0.94 |
| Short Interest | — | 52W High | 1.92 | 52W Low | 0.91 |
| Beta | 3.34 | Avg Volume | 311.80K | Volume | 41.93K |
| Target Price | $5.00 | Recom | None | Prev Close | $1.25 |
| Price | $1.27 | Change | 1.60% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$5.00
Mean price target
2. Current target
$1.27
Latest analyst target
3. DCF / Fair value
$-3.46
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.27
Low
$4.00
High
$7.00
Mean
$5.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-09-02 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-05-19 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-04-16 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-04-04 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-03-26 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-03-13 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-11-07 | init | HC Wainwright & Co. | — → Buy | $3 |
| 2022-12-05 | init | ThinkEquity | — → Buy | $7 |
- Vivani Medical Stock (VANI) Opinions on Insider Purchase - Quiver Quantitative hu, 16 Oct 2025 07
- Vivani chair backs $4.5M raise for long-acting drug implants - Stock Titan Sun, 25 Jan 2026 08
- Insiders hold 43% of Vivani Medical, Inc. (NASDAQ:VANI), and they've been buying recently - Yahoo Finance Fri, 05 Dec 2025 08
- Vivani medical director Williams buys $1.98 million in VANI stock - Investing.com hu, 16 Oct 2025 07
- Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat Fri, 13 Feb 2026 08
- Vani Commercials Limited Appoints Ms. Nikita Pal as Company Secretary and Compliance Officer - scanx.trade ue, 24 Feb 2026 13
- Top Vivani Medical Insider Makes Bold Multi-Million Dollar Move - TipRanks Wed, 18 Feb 2026 11
- Insiders Are Buying These 3 Stocks Hand Over Fist - 24/7 Wall St. ue, 28 Oct 2025 07
- Vani Commercials Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals - Markets Mojo ue, 24 Feb 2026 03
- Gregg Williams Bought 17% More Shares In Vivani Medical - simplywall.st Fri, 31 Oct 2025 07
- Insider Stock Purchases: February 17, 2026 - Quiver Quantitative ue, 17 Feb 2026 18
- Williams Gregg buys Vivani medical (VANI) shares worth $1.98 million By Investing.com - Investing.com South Africa ue, 17 Feb 2026 11
- Vivani Medical (NASDAQ:VANI) Director Acquires 1,351,351 Shares - MarketBeat Wed, 28 Jan 2026 08
- Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - Yahoo Finance Mon, 02 Jun 2025 07
- $VANI stock is up 8% today. Here's what we see in our data. - Quiver Quantitative Wed, 28 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1866492 | 1983333 | — | Purchase at price 1.03 - 1.26 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-13 00:00:00 | I |
| 1 | 1351351 | 1999999 | — | Purchase at price 1.48 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-27 00:00:00 | I |
| 2 | 1737765 | 1983334 | — | Purchase at price 1.12 - 1.26 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-15 00:00:00 | I |
| 3 | 20000 | 24600 | — | Purchase at price 1.23 per share. | MENDELSOHN AARON | Director | — | 2025-12-29 00:00:00 | D |
| 4 | 1737765 | 1983334 | — | Purchase at price 1.12 - 1.26 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-15 00:00:00 | I |
| 5 | 1737764 | 2425297 | — | Purchase at price 1.26 - 1.42 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-11-14 00:00:00 | I |
| 6 | 3703703 | 5999999 | — | Purchase at price 1.62 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-27 00:00:00 | I |
| 7 | 1737764 | 1983333 | — | Purchase at price 1.12 - 1.26 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-15 00:00:00 | I |
| 8 | 2068453 | 2400001 | — | Purchase at price 1.12 - 1.26 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-09-15 00:00:00 | I |
| 9 | 12740 | 12867 | — | Purchase at price 1.01 per share. | WILLIAMS GREGG | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-05-16 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -24.28M | -26.61M | -20.86M | -12.98M |
| TotalUnusualItems | 6.88M | 0.00 | ||
| TotalUnusualItemsExcludingGoodwill | 6.88M | 0.00 | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -23.49M | -25.65M | -13.89M | -12.77M |
| ReconciledDepreciation | 400.00K | 357.00K | 381.00K | 345.00K |
| EBITDA | -24.28M | -26.61M | -20.86M | -12.98M |
| EBIT | -24.68M | -26.96M | -21.24M | -13.32M |
| NormalizedIncome | -23.49M | -25.65M | -13.89M | -12.77M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -23.49M | -25.65M | -13.89M | -12.77M |
| TotalExpenses | 24.68M | 26.96M | 21.24M | 13.32M |
| TotalOperatingIncomeAsReported | -24.68M | -26.96M | -21.24M | -13.32M |
| DilutedAverageShares | 54.98M | 50.85M | 38.24M | 33.09M |
| BasicAverageShares | 54.98M | 50.85M | 38.24M | 33.09M |
| DilutedEPS | -0.43 | -0.50 | -0.36 | -0.39 |
| BasicEPS | -0.43 | -0.50 | -0.36 | -0.39 |
| DilutedNIAvailtoComStockholders | -23.49M | -25.65M | -13.89M | -12.77M |
| NetIncomeCommonStockholders | -23.49M | -25.65M | -13.89M | -12.77M |
| NetIncome | -23.49M | -25.65M | -13.89M | -12.77M |
| NetIncomeIncludingNoncontrollingInterests | -23.49M | -25.65M | -13.89M | -12.77M |
| NetIncomeContinuousOperations | -23.49M | -25.65M | -13.89M | -12.77M |
| PretaxIncome | -23.49M | -25.65M | -13.89M | -12.77M |
| OtherIncomeExpense | 1.19M | 1.31M | 7.35M | 550.00K |
| OtherNonOperatingIncomeExpenses | 1.19M | 1.31M | 7.35M | 550.00K |
| SpecialIncomeCharges | 6.88M | 0.00 | ||
| OtherSpecialCharges | -641.00K | |||
| RestructuringAndMergernAcquisition | -6.88M | 0.00 | ||
| OperatingIncome | -24.68M | -26.96M | -21.24M | -13.32M |
| OperatingExpense | 24.68M | 26.96M | 21.24M | 13.32M |
| ResearchAndDevelopment | 15.74M | 16.97M | 14.17M | 11.00M |
| SellingGeneralAndAdministration | 8.93M | 10.00M | 7.07M | 2.32M |
| GeneralAndAdministrativeExpense | 8.93M | 10.00M | 7.07M | 2.32M |
| OtherGandA | 8.93M | 10.00M | 7.07M | 2.32M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 59.23M | 51.03M | 50.74M | 50.73M |
| ShareIssued | 59.23M | 51.03M | 50.74M | 50.73M |
| TotalDebt | 19.31M | 20.70M | 955.00K | 1.81M |
| TangibleBookValue | 17.61M | 20.76M | 44.31M | 2.46M |
| InvestedCapital | 17.61M | 20.76M | 44.31M | 2.46M |
| WorkingCapital | 14.46M | 17.34M | 40.71M | 383.00K |
| NetTangibleAssets | 17.61M | 20.76M | 44.31M | 2.46M |
| CapitalLeaseObligations | 19.31M | 20.70M | 955.00K | 1.81M |
| CommonStockEquity | 17.61M | 20.76M | 44.31M | 2.46M |
| TotalCapitalization | 17.61M | 20.76M | 44.31M | 2.46M |
| TotalEquityGrossMinorityInterest | 17.61M | 20.76M | 44.31M | 2.46M |
| StockholdersEquity | 17.61M | 20.76M | 44.31M | 2.46M |
| GainsLossesNotAffectingRetainedEarnings | 48.00K | 140.00K | 35.00K | 0.00 |
| OtherEquityAdjustments | 48.00K | 140.00K | 35.00K | |
| RetainedEarnings | -121.92M | -98.44M | -72.79M | -58.90M |
| AdditionalPaidInCapital | 139.48M | 119.05M | 117.05M | 6.71M |
| CapitalStock | 6.00K | 5.00K | 5.00K | 54.65M |
| CommonStock | 6.00K | 5.00K | 5.00K | 54.65M |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 23.95M | 25.04M | 6.82M | 2.99M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 17.96M | 19.31M | 0.00 | 902.00K |
| LongTermDebtAndCapitalLeaseObligation | 17.96M | 19.31M | 0.00 | 902.00K |
| LongTermCapitalLeaseObligation | 17.96M | 19.31M | 0.00 | 902.00K |
| CurrentLiabilities | 5.99M | 5.72M | 6.82M | 2.09M |
| CurrentDebtAndCapitalLeaseObligation | 1.35M | 1.38M | 955.00K | 910.00K |
| CurrentCapitalLeaseObligation | 1.35M | 1.38M | 955.00K | 910.00K |
| LineOfCredit | 0.00 | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 343.00K | 396.00K | 657.00K | 0.00 |
| PayablesAndAccruedExpenses | 4.29M | 3.94M | 5.21M | 1.18M |
| CurrentAccruedExpenses | 3.48M | 3.40M | 4.03M | 895.00K |
| Payables | 817.00K | 542.00K | 1.18M | 281.00K |
| AccountsPayable | 817.00K | 542.00K | 1.18M | 281.00K |
| TotalAssets | 41.56M | 45.80M | 51.13M | 5.45M |
| TotalNonCurrentAssets | 21.12M | 22.73M | 3.60M | 2.98M |
| OtherNonCurrentAssets | 1.47M | 1.39M | 1.37M | |
| NonCurrentPrepaidAssets | 52.00K | 275.00K | 200.00K | |
| NetPPE | 19.65M | 21.34M | 1.96M | 2.78M |
| AccumulatedDepreciation | -2.64M | -2.44M | -2.41M | -2.03M |
| GrossPPE | 22.29M | 23.79M | 4.37M | 4.82M |
| Leases | 0.00 | 12.00K | 12.00K | |
| ConstructionInProgress | 0.00 | 299.00K | 0.00 | |
| OtherProperties | 21.89M | 23.13M | 4.30M | 4.79M |
| MachineryFurnitureEquipment | 397.00K | 361.00K | 61.00K | 18.00K |
| Properties | 0.00 | 0.00 | 0.00 | |
| CurrentAssets | 20.44M | 23.06M | 47.53M | 2.47M |
| OtherCurrentAssets | 1.84M | 2.41M | 2.45M | 291.00K |
| PrepaidAssets | 291.00K | |||
| Receivables | 253.00K | 0.00 | ||
| TaxesReceivable | 253.00K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 18.35M | 20.65M | 45.08M | 2.18M |
| CashAndCashEquivalents | 18.35M | 20.65M | 45.08M | 2.18M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -21.34M | -24.59M | -19.12M | -11.52M |
| IssuanceOfDebt | 426.00K | 0.00 | 0.00 | |
| IssuanceOfCapitalStock | 18.82M | 0.00 | 16.00K | 11.62M |
| CapitalExpenditure | -556.00K | -887.00K | -338.00K | -572.00K |
| IncomeTaxPaidSupplementalData | 2.00K | 1.00K | 0.00 | 1.00K |
| EndCashPosition | 19.69M | 21.99M | 46.44M | 2.18M |
| BeginningCashPosition | 21.99M | 46.44M | 2.18M | 2.08M |
| EffectOfExchangeRateChanges | -14.00K | 3.00K | -1.00K | 0.00 |
| ChangesInCash | -2.29M | -24.45M | 44.27M | 97.00K |
| FinancingCashFlow | 19.05M | 133.00K | 63.39M | 11.62M |
| CashFlowFromContinuingFinancingActivities | 19.05M | 133.00K | 63.39M | 11.62M |
| NetOtherFinancingCharges | -189.00K | 63.37M | ||
| ProceedsFromStockOptionExercised | 0.00 | 133.00K | ||
| NetCommonStockIssuance | 18.82M | 0.00 | 16.00K | 11.62M |
| CommonStockIssuance | 18.82M | 0.00 | 16.00K | 11.62M |
| NetIssuancePaymentsOfDebt | 426.00K | 0.00 | 0.00 | |
| NetShortTermDebtIssuance | 426.00K | 0.00 | 0.00 | |
| ShortTermDebtIssuance | 426.00K | 0.00 | 0.00 | |
| InvestingCashFlow | -556.00K | -887.00K | -338.00K | -572.00K |
| CashFlowFromContinuingInvestingActivities | -556.00K | -887.00K | -338.00K | -572.00K |
| NetPPEPurchaseAndSale | -556.00K | -887.00K | -338.00K | -572.00K |
| PurchaseOfPPE | -556.00K | -887.00K | -338.00K | -572.00K |
| OperatingCashFlow | -20.79M | -23.70M | -18.79M | -10.95M |
| CashFlowFromContinuingOperatingActivities | -20.79M | -23.70M | -18.79M | -10.95M |
| ChangeInWorkingCapital | 354.00K | -1.29M | 338.00K | 436.00K |
| ChangeInOtherWorkingCapital | 204.00K | |||
| ChangeInOtherCurrentLiabilities | 14.00K | |||
| ChangeInPayablesAndAccruedExpense | 116.00K | -1.56M | 814.00K | 334.00K |
| ChangeInAccruedExpense | -132.00K | -955.00K | 2.75M | 321.00K |
| ChangeInPayable | 248.00K | -602.00K | -1.94M | 13.00K |
| ChangeInAccountPayable | 248.00K | -602.00K | -1.94M | 13.00K |
| ChangeInPrepaidAssets | 491.00K | 264.00K | -476.00K | 102.00K |
| ChangeInReceivables | -253.00K | 0.00 | ||
| OtherNonCashItems | 276.00K | 904.00K | -6.91M | -627.00K |
| StockBasedCompensation | 1.61M | 1.86M | 1.30M | 1.67M |
| AssetImpairmentCharge | 60.00K | 121.00K | ||
| DepreciationAmortizationDepletion | 400.00K | 357.00K | 381.00K | 345.00K |
| DepreciationAndAmortization | 400.00K | 357.00K | 381.00K | 345.00K |
| OperatingGainsLosses | 121.00K | -641.00K | ||
| GainLossOnSaleOfPPE | 121.00K | 0.00 | ||
| NetIncomeFromContinuingOperations | -23.49M | -25.65M | -13.89M | -12.77M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for VANI
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|